OSMOTICA PHARMAC (Germany) Probability of Future Stock Price Finishing Over 0.0

OSMOTICA PHARMAC's future price is the expected price of OSMOTICA PHARMAC instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of OSMOTICA PHARMAC DL performance during a given time horizon utilizing its historical volatility.
  
Check out Your Equity Center.Please specify OSMOTICA PHARMAC time horizon, a valid symbol (red box) and a target price (blue box) you would like OSMOTICA PHARMAC odds to be computed.

OSMOTICA PHARMAC Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of OSMOTICA PHARMAC for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for OSMOTICA PHARMAC can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
OSMOTICA PHARMAC is not yet fully synchronised with the market data
OSMOTICA PHARMAC has some characteristics of a very speculative penny stock
OSMOTICA PHARMAC has high likelihood to experience some financial distress in the next 2 years
The company has accumulated 216.16 M in total debt with debt to equity ratio (D/E) of 3.16, implying the company greatly relies on financing operations through barrowing. OSMOTICA PHARMAC has a current ratio of 0.92, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist OSMOTICA PHARMAC until it has trouble settling it off, either with new capital or with free cash flow. So, OSMOTICA PHARMAC's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like OSMOTICA PHARMAC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for OSMOTICA to invest in growth at high rates of return. When we think about OSMOTICA PHARMAC's use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 189.86 M. Net Loss for the year was (76.85 M) with profit before overhead, payroll, taxes, and interest of 103.4 M.
OSMOTICA PHARMAC DL has accumulated about 99.78 M in cash with (13.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.59.
Roughly 31.0% of OSMOTICA PHARMAC outstanding shares are owned by corporate insiders

OSMOTICA PHARMAC Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of OSMOTICA Stock often depends not only on the future outlook of the current and potential OSMOTICA PHARMAC's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. OSMOTICA PHARMAC's indicators that are reflective of the short sentiment are summarized in the table below.
Float Shares19.95M
Average Daily Volume Last 10 Day2.4k
Average Daily Volume In Three Month338

OSMOTICA PHARMAC Technical Analysis

OSMOTICA PHARMAC's future price can be derived by breaking down and analyzing its technical indicators over time. OSMOTICA Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of OSMOTICA PHARMAC DL. In general, you should focus on analyzing OSMOTICA Stock price patterns and their correlations with different microeconomic environments and drivers.

OSMOTICA PHARMAC Predictive Forecast Models

OSMOTICA PHARMAC time-series forecasting models is one of many OSMOTICA PHARMAC's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary OSMOTICA PHARMAC's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about OSMOTICA PHARMAC

Checking the ongoing alerts about OSMOTICA PHARMAC for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for OSMOTICA PHARMAC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
OSMOTICA PHARMAC is not yet fully synchronised with the market data
OSMOTICA PHARMAC has some characteristics of a very speculative penny stock
OSMOTICA PHARMAC has high likelihood to experience some financial distress in the next 2 years
The company has accumulated 216.16 M in total debt with debt to equity ratio (D/E) of 3.16, implying the company greatly relies on financing operations through barrowing. OSMOTICA PHARMAC has a current ratio of 0.92, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist OSMOTICA PHARMAC until it has trouble settling it off, either with new capital or with free cash flow. So, OSMOTICA PHARMAC's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like OSMOTICA PHARMAC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for OSMOTICA to invest in growth at high rates of return. When we think about OSMOTICA PHARMAC's use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 189.86 M. Net Loss for the year was (76.85 M) with profit before overhead, payroll, taxes, and interest of 103.4 M.
OSMOTICA PHARMAC DL has accumulated about 99.78 M in cash with (13.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.59.
Roughly 31.0% of OSMOTICA PHARMAC outstanding shares are owned by corporate insiders
Check out Your Equity Center. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Tools for OSMOTICA Stock

When running OSMOTICA PHARMAC price analysis, check to measure OSMOTICA PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OSMOTICA PHARMAC is operating at the current time. Most of OSMOTICA PHARMAC's value examination focuses on studying past and present price action to predict the probability of OSMOTICA PHARMAC's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move OSMOTICA PHARMAC's price. Additionally, you may evaluate how the addition of OSMOTICA PHARMAC to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go